A Prospective Randomized Study to Examine the Effect of Aspirin Plus Dipyridamole on the Patency of Prosthetic Femoro-Popliteal Grafts

Abstract

When prosthetic materials are used in arterial reconstruction patency rates are less favourable due to the formation of platelet thrombus on the luminal surface. As platelet inhibitory drugs may reduce the rate of platelet accumula tion on such grafts, a randomised, double blind study has been undertaken to assess the effect of Aspirin and Dipyridamole on the patency of prosthetic fe moropopliteal bypass grafts. Drug or identical placebo therapy was started two days pre-operatively in 53 patients undergoing femoropopliteal bypass using either Dacron or Polytetrafluorethylene. Follow-up was for at least one year or until first occlusion, with patency assessed objectively. In the 28 patients on placebo cumulative patency by life table was 36% by 12 months compared to 67% on ASA/DPM (P < 0.05). In 37 patients with PTFE grafts, ASA/DPM en hanced one year patency from 50% to 80%. This drug combination therefore reduces prosthetic graft thrombosis in patients and must now be considered the standard against which new drugs should be compared.

Get full access to this article

View all access options for this article.

References

Callow AD : Current status of vascular grafts. Surg Clin North Amer 62:501-513, 1982.

McCollum CN , Crow MJ , Rajah SM , Kester RC : Antithrombotic therapy for vascular prosthesis. An experimental model testing platelet inhibitory drugs. Surgery 87:668-676, 1980.

Oblath RW , Buckley FO , Green RM , et al: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84:37-43, 1978.

Norcott HC , Goldman M. , Hawker RJ , et al: Platelet inhibitory drugs, an in vivo method of evaluation in patients. Thrombos Haemostas 48:307-310, 1982.

Donaldson DR , Kester RC , Hall TJ , et al: Do platelet-modifying agents influence the patency of femoro-popliteal Dacron bypass grafts? Br J Surg 69:284, 1982 (abstract).

Grimley RP , Obeid ML , Ashton F. , Slaney G. : Long term results of autogenous vein bypass grafts in femoro-popliteal arterial occlusion. Br J Surg 66:623-726, 1979.

Fielding Jwc , Hurlow RA , Slaney G. , Ashton F. : Early experience with polytetrafluorethylene femoro-popliteal grafts. Ann Roy Coll Surg (Eng) 61:486-487, 1979.

Green RM , Roedesheimer LR , DeWeese JA : Effects of aspirin and dipyridamole on expanded polytetrafluorethylene graft patency. Surgery 92:1016-1026, 1982 .

Eickhoff JH , et al: A randomised clinical trial of PTFE versus human umbilical vein or femoro-popliteal bypass surgery. Preliminary results. Br J Surg 70:85-88, 1983.

10.

Cheesbro JH , Clements IP , Fuster V. , et al: A platelet inhibitor drug trial on coronary artery bypass operations. Benefit of preoperative dipyridamole and aspirin therapy on early post operative vein graft patency. New Engl J Med 307:73-78, 1982.

11.

Hagen PO , Wang ZG , Mikat EM , Hacket DB : Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prosthese (PTFE) in nonhuman primates. Ann Surg 195:328-339, 1982.

12.

Goldman MD , Simpson D. , Hawker RJ , et al: Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Annals of Surgery (in press).

13.

Harker LA , Slichter SJ , Sauvage LR : Platelet comsumption by arterial prostheses: The effects of endothelialisation and pharmacologic inhibition of platelet function. Ann Surg 186:594-601, 1977.